People living with HIV and stigma in Togo: Key outcomes of the 2020 Stigma Index Survey
Julienne Noude Teclessou
1, Abla Sefako Akakpo1, Augustin Dokla2, Damien Kegnidé Amoussou3, Kodzo Deku3, Abalo Limazie3, Maboudou Akouavi4, Palokinam Pitche1,3
1Faculty of Health Sciences, University of Lome, Togo, 2National Network of People Living with HIV (RAS+ Togo), Togo, 3National AIDS Council of Togo, 4UNAIDS Office in Togo
Citation tools:
Copyright information
© Our Dermatology Online 2025. No commercial re-use. See rights and permissions. Published by Our Dermatology Online.
ABSTRACT
Background: The study of HIV-related stigma/discrimination issues enables the implementation of care and prevention interventions. The aim of this study was to assess stigma/discrimination against people living with HIV (PLHIV) from the population as a whole and key populations in Togo in 2020.
Method: This was a descriptive, cross-sectional study in the six health regions of Togo targeting PLHIV aged 18 years and over, including those from ley populations. The data was collected using the Stigma Index 2.0 questionnaire.
Results: A total of 1119 PLHIV from different groups were included. The median age of the respondents was 39 years, and the sex ratio was 0.48. Due to HIV status, 137 (12.2%) of those surveyed had already been excluded from social activities or meetings, and 33.6% had already been aware of discriminatory/stigmatizing comments about them from family members. Female-identifying respondents had experienced more stigma/gossip discrimination in the last 12 months (71.6%). Also, 54.4% of men having sex with men reported feeling excluded from family activities.
Conclusion: This study helps to note the persistence of certain forms of discrimination/stigma. To end the AIDS epidemic by 2030, efforts must be made to ensure a favorable environment in the implementation of interventions in the country.
Key words: HIV, Stigma, Togo
INTRODUCTION
Despite the global progress toward the goal of ending the AIDS epidemic as a public health threat by 2030 [1], stigma and discrimination cases are bottlenecks for access to care for HIV infection. Their studies enable to take mitigation measures to foster an environment that is favorable for the implementation of care and prevention interventions. Stigma is labeling, stereotyping, separation, loss of status, and discrimination of individuals or groups [2]. Internal stigma or self-stigmatization is acceptance of the perception of one’s lower status within society and is manifested in low self-esteem, isolation, and social withdrawal [3,4]. Stigma results in discrimination. Stigma toward people living with HIV (PLHIV) has been reported in several studies in Africa [5,6]. These issues of stigma and discrimination are a major bottleneck in the implementation of HIV and general health interventions; this has led the United Nations Programme on HIV/AIDS (UNAIDS) to make it one of the goals of the global AIDS plan to combat AIDS over the past decade [1].
Togo is a country with a mixed-type epidemic, and HIV seroprevalence appears stable (2.5% in 2014; 2% in 2019) in the general population. However, the epidemic remains highly concentrated among key populations since in 2017. Seroprevalence was estimated at 13.1% among female sex workers (FSWs), 21.9% among men who have sex with men (MSM), and 3.5% among drug users (DUs). This high prevalence among key populations may be linked to the discrimination and stigmatization that they face, which limits access to the services available in the countries. In a 2014 study in Togo [7], 37.9% of PLHIV reported experiencing at least one experience of stigma and discrimination from others in the past 12 months. Following the first survey in 2014, an observatory on stigma and discrimination led by the National Network of PLHIV Associations (RAS+) was established. The observatory initially targeted stigma issues related to HIV. Since 2016, it has integrated key populations. A number of awareness-raising and case management activities have been conducted. In addition, the National AIDS Council has developed service packages for the implementation of specific interventions on human rights and HIV aspects with the support of technical and financial partners.
Seven years after the first survey, it was necessary to conduct a new survey to assess the level of stigma and discrimination against PLHIV from the general population and key populations in Togo in 2020.
METHODOLOGY
Study Type and Scope
It was a national, descriptive, cross-sectional study that took place in all 44 districts of Togo’s six health regions. In the health districts, the survey was conducted at PLHIV sites and community-based structures for the management of key populations. The selection of survey sites was based on the UNAIDS “location and population” approach. It is, therefore, taken into account: the urban or rural location of the site; the weight of the active queue of PLHIV including those from key populations in each health region in the national active queue (burden of the epidemic); the existence of community-based organizations for PLHIV and key populations; and the existence of historical stigma data for comparison purposes.
Study Population
The study population consisted of PLHIV aged 18 years and over who had known their HIV status for more than 12 months; followed or not in structures of intake. The selection was made using the selected sampling procedure for the PLHIV subtype (general population, key population). Six subtypes were targeted: PLHIV of the general population, MSM, drug users (UD), sex worker (PS), transgender, former inmates. The identification of the different subtypes was done in collaboration with the platform of civil society organizations, key population organizations’ network, the National Program of Fight against AIDS (PNLS), and RAS+ member organizations.
Sampling
Hybrid sampling was used, combining limited chain referencing (LCR), sampling based on venue/activity mapping, random/systematic choice, and reasoned choice/convenience.
Based on data from the 2013 stigma index survey, about one in sixteen (1/16) PLHIV may decide to avoid seeking healthcare due to anticipated stigma based on HIV status, hence a probability (p) for PLHIV to avoid seeking healthcare of 6.3%. The Schwartz formula was used to estimate sample size:
- n: Minimum required sample size expressed as the number of individuals in the target population.
- p: Reference value of the target indicator, set at 6.3%.
- δ: Margin of error, set at 3.0% for all indicators.
- a: Statistical significance level, set for all indicators at 95%.
- deff: Cluster effect, set at 2.
The minimum sample size is, therefore, 1008 PLHIV. Assuming 10% of non-responses (i.e., 102 additional PLHIV), an adjusted sample size of 1110 was considered.
Given the need for the study population to be representative, and in view of the context, it was suggested that the final sample be made up of: 30% (i.e., 333) of PLHIV from key populations; 60% of PLHIV (i.e., 666) from the general population; and 10% (i.e., 111) of PLHIV who, because of severe stigmatization and discrimination, delay their engagement in care and become lost-to-sight (LTS) for some.
Data Collection
The questionnaire used is the one developed by the international partnership for the PLHIV Stigma Index (Stigma Index 2.0). It consists of seventy-eight questions divided into eight sections. Two phases preceded the survey itself:
- The preparatory phase consisted of going to the field to inform the actors and select the investigators.
- Investigator training and 5-day pilot investigation. A pre-test was conducted in 30 PLHIV, which allowed to take into account the difficulties of investigators.
Data Analysis
Analysis was performed using SPSS v23.0 software. Data was disaggregated according to general respondent characteristics and other variables of interest according to context. A comparative analysis of proportions was conducted using the chi-2 test for independent samples. The test validation threshold was set at 95%.
Consent and Ethical Aspects
The protocol of the study was approved by the bioethics committee for health research of the Togo Ministry of Health (opinion N° 015/CBRS of 25 September 2020). All data was collected and processed anonymously. An information note and informed consent form were signed by each respondent.
RESULTS
A total of 1119 PLHIV from the general population and subtypes were included, at 98 sites across the six health regions. The median age of the respondents was 39 years (extremes: 18 to 80 years), with the 30–39 age group the most represented (28.2%) (Table 1). The sex ratio was 0.48, and according to gender identity, 69.4% of respondents identified themselves as women. The highest level of education was secondary school or equivalent (408 or 36.5%). Among the respondents, 368 (32.9%) were unemployed; 490 (43.4%) had known they were HIV-positive for 1–4 years; and 36.9% had declared that their sexual partner(s) were also HIV-positive.
Status Disclosure
Overall, 81.3% of the respondents reported that it was difficult for them to share their HIV status with a third person and 86.8% reported hiding their HIV status from others. 400 respondents (35.7%) said their partners were aware of their HIV status; and in 27% of cases, this disclosure was made without their consent (Table 1). Also, 24.3% said their children were aware of their HIV status. For 51.4% of respondents, disclosing their HIV status to relatives was not a positive experience and 46.1% said that their loved ones showed no support in learning about their HIV status.
Experiences of Stigma and Discrimination due to HIV Status
One hundred and thirty-seven (12.2%) of whom 4.8% in the past 12 months preceding the survey reported that they had already been excluded from social activities or meetings because of their HIV status (Table 2). In addition, 376 (33.6%) of those surveyed had already been aware of discriminatory comments or gossip about them from family members, 14.7% of whom had been in the past 12 months (Table 2). 378 (33.8%) had at least once become aware of discriminatory remarks or gossip about them from others (beyond their families). Verbal harassment was reported by 294 (26.3%), among whom 12.0% in the last 12 months.
Respondents who had experienced stigmatization or discrimination in the last 12 months were significantly higher among those identifying themselves as women (both in terms of exclusion from social gatherings (53.7%; p = 0.00); exclusion from religious activities (45.5%; p = 0.00) and discrimination/gossip from others outside the family (70.7%; p = 0.000). However, respondents identifying themselves as men were more likely to be discriminated against by spouses/sexual partners/children (34.2%) or excluded from family activities (32.4%). The 30–39 age group was more excluded from social activities/meetings (50%, p = 0.02) or religious activities/places of worship (60.6%; p = 0.003) in the last 12 months. One hundred and thirteen (10.1%) respondents reported ever having been refused or lost a job because of their HIV status, including 5.5% in the last 12 months.
Internalized Stigma and Resilience of Respondents
Self-confidence was negatively influenced in 381 (34.0%) of the respondents and 387 (34.6%) of the respondents had a negative influence on their ability to find love (Table 3). Female respondents felt much more self-stigmatized over the past 12 months for both “my respect for myself” (66.4%, p = 0.000) and “my desire to have children” (61.8%; p = 0.01) (Table 4). Depending on age, respondents aged 30 to 39 and those aged 40 to 49 were more negatively influenced on “respect for myself (25.5% and 25.9%, respectively; p = 0.000); my ability to find love (26.1% and 25.3%, respectively; p = 0.000).
![]() |
Table 3: Distribution of respondents who experienced feelings of self-stigma because of HIV status in the past 12 months. |
![]() |
Table 4: Double stigma among people living with HIV. |
Over the past 12 months, the self-stigmatizing behaviors of respondents were: deciding not to have sex (405 respondents or 36.2%); isolating themselves from family and/or friends (311 or 27.8%); not participating in social gatherings (321; or 28.7%); avoiding going to a health center or hospital when one needed it (204 or 18.2%); not applying for a job (135 or 12.1%), or choosing not to use social support (211 or 18.9%).
Six hundred and forty-two (57.4%) respondents felt ashamed; 608 (54.3%) felt guilty; 474 (42.4%) sometimes felt useless. As a function of age, apart from the behavior “decided not to have sex,” which was significantly higher for those aged 40–49 (28.9%).
Experiences of Stigma and Discrimination on Grounds other than HIV Status
In terms of gender identity, 64.9% of the 94 transgender respondents had reported being verbally harassed by someone, and 62.8% had felt excluded from family activities. Also, 62 (54.4%) of the 114 gay/homosexual/MSM respondents said they had felt excluded from family activities, including 41 (36.0%) in the last 12 months, and 76 (66.7%) said they had felt that family members had made discriminatory or slanderous remarks about them, including 26 (22.8%) in the last 12 months (Table 4). Twenty-one (56.7%) of the 37 bisexual respondents, including 14 (37.8%) in the last 12 months, had already avoided using health services for fear of someone learning their identity. Forty-three (59.8%) of the 72 DU had already been verbally harassed by a third party, including 31 (43.1%) in the last 12 months.
DISCUSSION
The originality of this second study is to have integrated key populations (sex workers, men who have sex with other men and transgender people) infected with HIV and other parameters such as double stigma in contrast to the first 2013 study. The study shows that issues of stigma and discrimination related to HIV are still prevalent in Togo with some populations such as women and MSM being exposed.
In this study, 33.6% of the respondents were victims at least once of discriminatory remarks or gossip from family members and others. This frequency was 37.9% in the same population in the 2014 survey [7]; this documents a slight downward trend or at least the stabilization of this phenomenon in Togo.
HIV-related stigma and discrimination are one of the bottlenecks in the fight against HIV in sub-Saharan Africa. In 2007 in South Africa, 45% of men and 40% of women had experienced discrimination since their HIV status [8]. These frequencies are even higher when it comes to MSM and sex workers [9,10]. Double discrimination is a factor limiting access to services for these populations, hence the need to continue working in our countries to create a social and legal environment favorable to these key populations [11]. In Canada, Lazarus et al. noted a significant association between occupational stigma among sex workers and barriers to access to care [12].
In addition, stigma within the family and the community is often the most prevalent and may contribute to limiting the sharing of HIV status by PLHIV, sometimes with a negative impact on treatment adherence [11,13]. In Tanzania, Kilewo et al. [14] reported that HIV-related stigma was one of the main reasons why women did not disclose their HIV status. Self-stigmatization takes several forms: shame, withdrawal, and guilt [8,15–17]. In our study, 57.4% of respondents felt ashamed of their HIV status. This phenomenon of self-stigmatization is more marked among women in African studies [18,19], in the context of vulnerability to gender-based violence. In fact, self-stigmatizing behavior contributes to limiting the socialization and self-fulfillment of PLHIV, with risks of self-exclusion from health centers and increased mental health problems not sufficiently taken into account in the HIV program in Africa.
CONCLUSION
The results show the persistence and pervasiveness of PLHIV stigma issues in Togo, despite awareness-raising efforts over the past several years. Building on this evidence, which is one of the bottlenecks in the fight against HIV, Togo has developed an operational plan on gender and HIV human rights covering 2022–2025 to help shape these phenomena and create an enabling environment for the implementation of HIV interventions with a view to achieving SDG3 (ending the AIDS epidemic as a public health problem) by 2030.
ACKNOWLEDGMENT
The authors would like to thank UNAIDS, USAID, RAS+, civil society organizations, the network of key population organizations and all those who contributed to this study.
Statement of Human and Animal Rights
All the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 2008 revision of the Declaration of Helsinki of 1975.
Statement of Informed Consent
Informed consent for participation in this study was obtained from all patients.
REFERENCES
1. UNAIDS. Ending AIDS:Progress towards the 90–90–90 targets. Geneva. 2017.
2. Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27:363-85.
3. Mak WWS, Cheung RYM, Law RW, Woo J, Li PCK, Chung RWY. Examining attribution model of self-stigma on social support and psychological wellbeing among people with HIV+/AIDS. Soc Sci Med. 2007;64:1549-59.
4. Meyer IH. Minority stress and mental health in gay men. J Health Soc Behav. 1995;36:38-56.
5. Hladik W, Barker J, Ssenkusu JM, Opio A, Tappero JW, Hakim A, et al. HIV infection among men who have sex with men in Kampala, Uganda:A respondent driven sampling survey. PLoS One. 2012;7:38143.
6. Peitzmeier SM, Grosso A, Bowes A, Ceesay N, Baral SD. Associations of stigma with negative health outcomes for people living with HIV in the Gambia:Implications for key populations. J Acquir Immune Defic Syndr. 2015;68:S146.
7. Saka B, Tchounga B, Ekouevi DK, Sehonou C, Sewu E, Dokla A, et al. Stigma and discrimination experienced by people living with HIV in Togo, in 2013. Santépublique. 2017;29:897-907.
8. Simbayi LC, Strebel A, Cloete A, Henda N, Mqeketo A. Details for manuscript number SSM-D-06-00290R2 “Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa.“Soc Sci Med. 2007;64:1823-31.
9. Abubakari GM, Dada D, Jemal N, Turner D, Otchere A, Tanis L, et al. Intersectional stigma and its impact on HIV prevention and care among MSM and WSW in sub-Saharan African countries:A protocol for a scoping review. BMJ 2021;11:047280.
10. Villiers L, Thomas A, Jivan D, Hoddinott G, Hargreaves JR, Bond V, et al. team. Stigma and HIV service access among transfeminine and gender diverse women in South Africa:A narrative analysis of longitudinal qualitative data from the HPTN 071 (PopART) trial. BMC Public Health. 2020;20:1898.
11. Sweeney SM, Mitzel LD, Vanable PA. Impact of HIV-related stigma on medication adherence among persons living with HIV. Curr Opin Psychol. 2015;5:96-100.
12. Lazarus L, Deering KN, Nabess R, Gibson K, Tyndall MW, Shannon K. Occupational stigma as a primary barrier to health care for street-based sex workers in Canada. Cult Health Sex. 2012;14:139-50.
13. Karamouzian MM, Akbari AH, Haghdoost AA, Setayesh H, Zolala F. “I am dead to them“:HIV-related stigma experienced by people living with HIV in Kerman. J Assoc Nurses AIDS Care 2015;26:46-56.
14. Kilewo C, Massawe A, Lyamuya E, Semali I, Kalokola F, Urassa E, et al. HIV Counselling and testing of pregnant women in sub-Saharan Africa:Experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2001;28:458-62.
15. Sawilowsky S. New effect size rules of thumb. J Mod Appl Stat Method. 2009;8:467-74.
16. Varga CA, Sherman GG, Jones SA. HIV-disclosure in the context of vertical transmission:HIV-positive mothers in Johannesburg, South Africa. AIDS Care. 2006;18:952-60.
17. Chandra PS, Deepthivarma S and Manjula V. Disclosure of HIV infection in South India:Patterns, reasons and reactions. AIDS Care. 2003;15:207-15.
18. MacLean JR, Wetherall K. The Association between HIV-stigma and depressive symptoms among people living with HIV/AIDS:A systematic review of studies conducted in South Africa. J Affect Disord. 2021;287:125-37.
19. Perez A, Brittain K, Phillips N, Stein DJ, Zar HI, Myer L, et al. HIV-related stigma and psychological adjustment among perinatally HIV-infected youth in Cape Town, South Africa. AIDS Behav. 2022;26:434-42.
Source of Support: The study was funded by UNAIDS and USAID as part of the implementation of the 2016-2020 National AIDS Strategic Plan in Togo
Copyright by authors of this article. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Request permissions
If you wish to reuse any or all of this article please use the e-mail (contact@odermatol.com) to contact with publisher.
| Related Articles | Search Authors in |
|
|
http://orcid.org/0000-0003-2619-8396 http://orcid.org/0000-0002-5844-0856 |
Rights and permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.








Comments are closed.